Company: ABLV
Filing Date: 2025-04-23
Form Type: 20-F
Source: 0001213900-25-034677
Chunk: 134

Company: Able View Global Inc.
Filing Date: 2025-04-23
Form: 20-F
Item: Item 6
Chunk 134
---
 required to disclose compensation paid to our senior management on an individual basis and we have not otherwise publicly
disclosed this information elsewhere. In 2024, our directors and management receive fixed and variable compensation. The fixed component
of their compensation is set on market terms and adjusted annually. The variable component consists of cash bonuses. Cash bonuses are
paid to executive officers and members of our senior management based on previously agreed targets for the business.

The aggregate cash compensation
accrued to Able View’s directors and executive officers who were employed by Able View in fiscal year 2024 was approximately US$310,569.

The Company is developing an executive compensation
program that is consistent with existing compensation policies and philosophies of Nasdaq-listed peer companies, which are designed to
align the interest of executive officers with those of its stakeholders, while enabling the Company to attract, motivate and retain individuals
who contribute to the long-term success of the Company.

C. Board Practices

Foreign Private Issuer and Controlled Company

We are a foreign private issuer within the meaning
of the rules under the Exchange Act and, as such, the Company is permitted to follow the corporate governance practices of its home
country, the Cayman Islands, in lieu of the corporate governance standards of Nasdaq applicable to U. S. domestic companies. For example,
the Company is not required to have a majority of the board consisting of independent directors nor have a compensation committee or a
nominating and corporate governance committee consisting entirely of independent directors. the Company may elect to follow its home country’s
corporate governance practices as long as its remains a foreign private issuer. As a result, our shareholders may not have the same protection
afforded to shareholders of U. S. domestic companies that are subject to Nasdaq corporate governance requirements. As a foreign private
issuer, the Company is also subject to reduced disclosure requirements and are exempt from certain provisions of the U. S. securities
rules and regulations applicable to U. S. domestic issuers such as the rules regulating solicitation of proxies and certain insider
reporting and short-swing profit rules. Nonetheless, the Company intends to align itself with the practices adopted by Nasdaq-listed U. S. domestic
companies to the best of its ability to provide its shareholders with enhanced transparency and protection.

We are a “controlled company” as defined
under the rules of Nasdaq, because Healthy Great Investing Company Limited is able to exercise approximately 91.0% of the aggregate voting
power of our total